Analysts and Calls -- UBS Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Analysts and Calls -- UBS

Public Reply Prvt Reply Mark as Last Read File

Previous 10 PreviousNext

To: Icebrg who started this subject	4/8/2003 4:48:18 AM
From: Icebrg	of 19

Conflict Issue Over Analyst's Deal By LANDON THOMAS Jr. [NYT] April 8, 2003 Meirav Chovav, a biotechnology stock analyst at Credit Suisse First Boston, agreed last April to join UBS Warburg, whose health care banking group is led by Benjamin Lorello. Her compensation: a guaranteed $10 million over three years, say bankers with a knowledge of her contract. Message 18810974

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 PreviousNext